Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 December 2018 | Story Leonie Bolleurs | Photo Barend Nagel
Marcelle Vermeulen
Marcele Vermeulen, a graduate from the Department of Plant Sciences, explores possible threats to crop production; contributing to food security in South Africa.

Global food security is currently threatened both by climate change and the low diversity of crops relied on by humankind to feed a growing world population. Marcele Vermeulen, a graduate in the Department of Plant Sciences who will receive her PhD at the December graduation ceremonies at the University of the Free State (UFS), is part of a team that is working hard to add to the diversity of staple foods in South Africa.

In the drive to focus on alternative crops, Marcele is researching the crop, Amaranthus cruentus, (grain amaranth). It is more tolerant to environmental stress for large-scale production, thereby also diversifying staple crops.

Relatively new development

“Amaranthus cruentus is an excellent candidate due to its high nutritional value and tolerance to drought and high temperatures. It can be mixed with conventional maize meal, to increase the protein intake of its consumers,” said Marcele.

The production of A. cruentus as a grain crop in South Africa is a relatively new development.

In her research, exploring the possible threats to crop production and paying particular attention to dominant plant pathogens in the Amaranthus cruentus, Marcele found a correlation between fungal pathogens and insect pests. 

Insect pests can influence plant diseases

Although reports on fungal pathogens and pests specific to A. cruentus are limited to and information for South Africa is limited to this study, there is a possibility that by controlling insect pests such as weevils, one might also be able to control fungal pathogens of Amaranthus cruentus.

Marcele believes that control of weevil pests should thus be the focus of future pest and pathogen management strategies and breeding programmes in A. cruentus.  

“Knowledge gained in my thesis will hopefully aid in the development of future cultivation practices, integrated pest/pathogen management programmes, as well as for the registration of crop protection products for A. cruentus,” Marcele added.

Research Contributes to Food Security from University of the Free State on Vimeo.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept